Aberrant lactate dehydrogenase A signaling contributes metabolic signatures in pancreatic cancer

BACKGROUND: Pancreatic cancer (PC) has the lowest 5-year survival rate; therefore, new early screening methods and therapeutic targets are still urgently required. Emerging technologies such as metabolomic-based liquid biopsy may contribute to the field. We found aberrant lactate dehydrogenase A (LD...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Wenna, Qiao, Lu, Zuo, Duo, Qin, Di, Xiao, Jiawei, An, Haohua, Wang, Yanhui, Zhang, Xinwei, Jin, Yu, Ren, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944301/
https://www.ncbi.nlm.nih.gov/pubmed/33708985
http://dx.doi.org/10.21037/atm-21-295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944301/
https://www.ncbi.nlm.nih.gov/pubmed/33708985
http://dx.doi.org/10.21037/atm-21-295

Ejemplares similares